WATSON LABS INC FDA Approval ANDA 202053

ANDA 202053

WATSON LABS INC

FDA Drug Application

Application #202053

Documents

Letter2014-09-16
Label2014-09-23

Application Sponsors

ANDA 202053WATSON LABS INC

Marketing Status

Discontinued001

Application Products

001SOLUTION/DROPS;OPHTHALMICEQ 2% BASE0DORZOLAMIDE HYDROCHLORIDEDORZOLAMIDE HYDROCHLORIDE

FDA Submissions

N/A; Not ApplicableORIG1AP2014-09-11

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAT

CDER Filings

INDOCO
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 202053
            [companyName] => INDOCO
            [docInserts] => ["",""]
            [products] => [{"drugName":"DORZOLAMIDE HYDROCHLORIDE","activeIngredients":"DORZOLAMIDE HYDROCHLORIDE","strength":"EQ 2% BASE","dosageForm":"SOLUTION\/DROPS;OPHTHALMIC","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => [{"actionDate":"09\/11\/2014","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/202053Orig1s000lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"09\/11\/2014","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Not Applicable","reviewPriority":"","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/202053Orig1s000lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2014\\\/202053Orig1s000ltr.pdf\"}]","notes":">"}]
            [supplements] => 
            [actionDate] => 2014-09-11
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.